Longeveron (LGVN) Deferred Taxes (2020 - 2023)
Longeveron (LGVN) posted quarterly Deferred Taxes of -$1.3 million for Q2 2023, down 8886.67% year-over-year from $15341.4 in Q2 2022, and down 2596.0% quarter-over-quarter from -$50000.0 in Q1 2023.
Longeveron (LGVN) Deferred Taxes (2020 - 2023) Analysis & Trends
Longeveron's Deferred Taxes history runs 4 years deep, the most recent figure standing at -$1.3 million for Q2 2023.
- In Q2 2023, Deferred Taxes fell 8886.67% year-over-year to -$1.3 million; the TTM figure through Dec 2023 stood at -$1.4 million (changed N/A YoY), while the FY2023 annual figure was -$1.4 million, down 355.37% from the prior year.
- Deferred Taxes for Q2 2023 stood at -$1.3 million, down from -$50000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $339000.0 in Q2 2020, with the low at -$1.3 million in Q2 2023.
- The 4-year median for Deferred Taxes is -$5500.0 (2021), against an average of -$114583.3.
- The sharpest annual moves came in 2021 and 2023: Deferred Taxes surged 113.86% in 2021, then tumbled 8886.67% in 2023.
- Longeveron's Deferred Taxes stood at $232000.0 in 2020, then tumbled by 98.28% to $4000.0 in 2021, then sank by 475.0% to -$15000.0 in 2022, then sank by 8886.67% to -$1.3 million in 2023.
- Business Quant data shows LGVN's Deferred Taxes at -$1.3 million in Q2 2023, -$50000.0 in Q1 2023, and -$15000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Longeveron | 26.51 Mn | 16.41 Mn | 182,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -1.35 Mn |
| Mar 31, 2023 | -50,000.00 |
| Jun 30, 2022 | -15,000.00 |
| Mar 31, 2022 | -306,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 28,000.00 |
| Jun 30, 2021 | 155,000.00 |
| Mar 31, 2021 | -375,000.00 |
| Dec 31, 2020 | 232,000.00 |
| Sep 30, 2020 | -202,000.00 |
| Jun 30, 2020 | 339,000.00 |
| Mar 31, 2020 | 163,000.00 |